Search

Author/Creator Prout, Toby

3. Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors. Issue 6 (18th June 2022)

Authors:
Papadatos-Pastos, Dionysis; Yuan, Wei; Pal, Abhijit; Crespo, Mateus; Ferreira, Ana; Gurel, Bora; Prout, Toby; Ameratunga, Malaka; Chénard-Poirier, Maxime; Curcean, Andra; Bertan, Claudia; Baker, Chloe; Miranda, Susana; Masrour, Nahal; Chen, Wentin; Pereira, Rita; Figueiredo, Ines; Morilla, Ricard...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Preliminary evidence of antitumour activity of Ipatasertib (Ipat) and Atezolizumab (ATZ) in glioblastoma patients (pts) with PTEN loss from the Phase 1 Ice-CAP trial (NCT03673787). (15th October 2021)

Authors:
Tiu, Crescens; Welsh, Liam; Jones, Timothy; Zachariou, Anna; Prout, Toby; Turner, Alison; Daly, Rob; Tunariu, Nina; Riisnaes, Ruth; Gurel, Bora; Crespo, Mateus; Carreira, Suzanne; Vivanco, Igor; Jenkins, Ben; Yap, Christina; Minchom, Anna; Banerji, Udai; deBono, Johann; Lopez, Juanita
Journal:
Neuro-oncology
Issue:
Volume 23: Supplement 4(2021)
Page Start:
iv10
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗